Hubei Wushi Pharmaceutical

Hubei Wushi Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company headquartered in Anlu, Hubei Province, with a history dating back to the early 1970s as the Hubei Anlu Pharmaceutical Factory. Formally established as a private joint-stock enterprise in 1997, the company integrates the research, development, production, and distribution of Traditional Chinese Medicine (TCM) and chemical drugs. Its core product portfolio includes the ANYAO brand, featuring leading products such as Jinyinhua lu (Honeysuckle flower distillate) and Wushicha keli (Noon tea granule). Closely affiliated with Waterstone Pharmaceuticals (Huashitong), Hubei Wushi serves as a key manufacturing and R&D partner for innovative small molecule candidates like WS019, which targets influenza and metabolic disorders. The company operates extensive GMP-certified facilities and is active in conducting bioequivalence trials for major generic medications.